SCHEMBL2829165

SCHEMBL2829165

Ic1cc(Oc2c(I)c[c]cc2I)cc(I)c1OCC1CO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.41
▸ TP53 P04637 3/20 0.41
▸ TSHR P16473 3/20 0.41
▸ HIF1A Q16665 3/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.38
▸ GLA P06280 1/20 0.36
▸ PPARG P37231 4/20 0.35
▸ THRB P10828 4/20 0.35
▸ THRA P10827 3/20 0.35
▸ RXRA P19793 3/20 0.35
▸ ITGB3 P05106 1/20 0.35
▸ ITGAV P06756 1/20 0.35
▸ MEN1 O00255 5/20 0.34
▸ KMT2A Q03164 5/20 0.34
▸ LMNA P02545 4/20 0.34
▸ MAPT P10636 3/20 0.34
▸ HPGD P15428 3/20 0.34
▸ CYP1A2 P05177 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1525949 0.81 MGLL (0.46) ALDH1A1HIF1ACYP3A4SMN1; SMN2PPARG
SCHEMBL1526072 0.80 THRB (0.61) ALDH1A1TSHRHIF1ACYP3A4SMN1; SMN2
SCHEMBL6013761 0.76 ALDH1A1 (0.47) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL14239796 0.75 MGLL (0.43) ALDH1A1HIF1ACYP3A4SMN1; SMN2PPARG
SCHEMBL12837225 0.74 THRB (0.56) ALDH1A1HIF1ACYP3A4SMN1; SMN2PPARG
SCHEMBL1525951 0.74 THRB (0.40) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL1525943 0.73 EPHX2 (0.42) ALDH1A1CYP3A4SMN1; SMN2PPARGTHRB
SCHEMBL19309251 0.73 THRB (0.43) ALDH1A1TP53TSHRHIF1ACYP3A4
SCHEMBL1525910 0.72 THRB (0.43) ALDH1A1TSHRHIF1ACYP3A4SMN1; SMN2
SCHEMBL1525948 0.72 THRB (0.38) ALDH1A1TP53TSHRHIF1ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2442800-B1 NANOPARTICLE AND POLYMER FORMULATIONS FOR THYROID HORMONE, ANALOGS, ANTAGONISTS, AND FORMULATIONS AND USES THEREOF NANOPHARMACEUTICALS LLC (US) 2019-04-24 — — EP disclosed
EP-2662079-A1 Uses of formulations of thyroid hormone antagonists and nanoparticulate forms thereof to increase chemosensivity and radiosensitivity in tumor or cancer cells Ordway Research Institute, Inc. (US) 2013-11-13 — — EP disclosed
WO-2010148007-A2 NANOPARTICLE AND POLYMER FORMULATIONS FOR THYROID HORMONE, ANALOGS, ANTAGONISTS, AND FORMULATIONS AND USES THEREOF ORDWAY RESEARCH INSTITUTE, INC. (US) 2010-12-23 — — WO disclosed
Send feedback